Archive \ Volume.13 2022 Issue 2

Cutaneous Manifestations and Types of skin affection Associated with COVID-19 Infection: A simple Review Article

, , ,

Abstract

Although COVID-19 is best known for causing fever and respiratory symptoms, it has been reported to be associated also with different extra pulmonary manifestations, including dermatological signs. Whilst the COVID-19-associated cutaneous manifestations have been increasingly reported that were unexpected before their onset, their exact incidence has yet to be estimated. Furthermore, evidence is accumulating that skin manifestation associated with COVID-19 are extremely polymorphic. This review article aimed to explore the updated evidence regarding the cutaneous manifestation associated with Covid-19 infection during the pandemic. COVID-19. Associated cutaneous manifestations have an extremely polymorphic nature including (i) urticarial rash, (ii) confluent erythematous/maculopapular/morbilliform rash, (iii) papulovesicular exanthem, (iv) chilblain-like acral pattern, (v) livedo reticularis/racemosa-like pattern, (vi) purpuric “vasculitic” pattern…. etc. Skin eruptions vary in morphology, time of onset, location, and duration. The incidence of cutaneous involvement in COVID-19 varies from 1% to 20% in different reports. The exact mechanism of cutaneous involvement in COVID-19 is not precise, the role, direct or indirect, of SARS-CoV-2 in their pathogenesis, is still debated but the pathogenesis probably involves high interferon.


Downloads: 187
Views: 773

How to cite:
Vancouver
Alenazy AES, Alabdulwahab K, Alabdulwahab F, Alanazi SIS. Cutaneous Manifestations and Types of skin affection Associated with COVID-19 Infection: A simple Review Article. Arch Pharm Pract. 2022;13(2):94-8. https://doi.org/10.51847/5HMEAOuDU6
APA
Alenazy, A. E. S., Alabdulwahab, K., Alabdulwahab, F., & Alanazi, S. I. S. (2022). Cutaneous Manifestations and Types of skin affection Associated with COVID-19 Infection: A simple Review Article. Archives of Pharmacy Practice, 13(2), 94-98. https://doi.org/10.51847/5HMEAOuDU6

Download Citation
References

1.        Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

2.        Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‐33.

3.        Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China. JAMA. 2020;323(8):709. doi:10.1001/jama.2020.1097

4.        Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS‐CoV‐2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45.

5.        Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708‐20.

6.        Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183(3):431-42.

7.        Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19? Int J Antimicrob Agents. 2020;56(2):106024. doi:10.1016/j.ijantimicag

8.        Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease(COVID-19) outbreak. J Autoimmun. 2020;109:102433.

9.        Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. AGRO, complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID‐19 infection: a report of five cases. Transl Res. 2020;220:1-13.

10.      Suchonwanit P, Leerunyakul K, Kositkuljorn C. Diagnostic and prognostic values of cutaneous manifestations in COVID-19. Dermatol Ther. 2020;2020:e13650. doi:10.1111/dth.13650

11.      Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, et al. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol. 2020;34(11):e686.

12.      Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-7.

13.      Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5). doi:10.1111/jdv.16387

14.      Rahimi H, Tehranchinia Z. A comprehensive review of cutaneous manifestations associated with COVID-19. Biomed Res Int. 2020;2020:1236520. doi:10.1155/2020/1236520

15.      Potekaev NN, Zhukova OV, Protsenko DN, Demina OM, Khlystova EA, Bogin V. Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification. Int J Dermatol. 2020;59(8):1000-9.

16.      Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol. 2020;34(11):2499-504.

17.      Criado PR, Abdalla BMZ, de Assis IC, van Blarcum de Graaff MC, Caputo GC, Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020;69(8):745-56. doi:10.1007/s00011-020-01370-w

18.      Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson RM. Comment on “Cutaneous manifestations in COVID-19: a first perspective” by Recalcati S. J Eur Acad Dermatol Venereol. 2020;34(7):e299-300. doi:10.1111/jdv.16519

19.      Cepeda-Valdes R, Carrion-Alvarez D, Trejo-Castro A, Hernandez-Torre M, Salas-Alanis J. Cutaneous manifestations in COVID-19: familial cluster of urticarial rash. Clin Exp Dermatol. 2020;45(7):895-6.

20.      Najafzadeh M, Shahzad F, Ghaderi N, Ansari K, Jacob B, Wright A. Urticaria (angioedema) and COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(10):e568-70.

21.      Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M. Urticaria‐like lesions in COVID‐19 patients are not really urticaria – a case with clinicopathologic correlation. J Eur Acad Dermatol Venereol. 2020;34(9):e459-60. doi:10.1111/jdv.16618

22.      Hassan K. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection. BMJ Case Rep. 2020;13(7):e236981.

23.      Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: lessons learned from current evidence. J Am Acad Dermatol. 2020;83(1):e57-e60. doi:10.1016/j.jaad.2020.04.094

24.      Imbalzano E, Casciaro M, Quartuccio S, Minciullo PL, Cascio A, Calapai G, et al. Association between urticaria and virus infections: A systematic review. Allergy Asthma Proc. 2016;37(1):18-22.

25.      Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020;34(7):e306-7. doi:10.1111/JDV.16530

26.      Diotallevi F, Campanati A, Bianchelli T, Bobyr I, Luchetti MM, Marconi B, et al. Skin involvement in SARS-CoV-2 infection: Case series. J Med Virol. 2020. doi:10.1002/jmv. 26012

27.      Mungmungpuntipantip R, Wiwanitkit V. COVID‐19 and cutaneous manifestations. J Eur Acad Dermatol Venereol. 2020;34(6):e246. doi:10.1111/jdv.16483

28.      Yong SB, Yeh WC, Wu HJ, Chen HH, Huang JY, Chang TM, et al. Impact of mycoplasma pneumonia infection on urticaria: A nationwide, population-based retrospective cohort study in Taiwan. PLoS One. 2019;14(12):e0226759.

29.      Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3.

30.      Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118-29.

31.      Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020;34:e346-7.

32.      van Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(7):e300-1.

33.      Kolivras A, Dehavay F, Delplace D, Feoli F, Meiers I, Milone L, et al. Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings. JAAD Case Rep. 2020;6(6):489-92.

34.      Docampo-Simón A, Sánchez-Pujol M, Juan-Carpena G, Palazón-Cabanes J, Vergara-De Caso E, Berbegal L, et al. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review. J Eur Acad Dermatol Venereol. 2020;34(9):e445-7. doi:10.1111/jdv.16665

35.      Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: transient livedo reticularis. J Am Acad Dermatol. 2020;83(2):700. doi:10.1016/j.jaad.2020.04.018

36.      Ahouach B, Harant S, Ullmer A, Martres P, Bégon E, Blum L, et al. Cutaneous lesions in a patient with COVID-19: are they related? Br J Dermatol. 2020;183(2):e31. doi:10.1111/bjd.19168

37.      Al Aboud AM, Manna B. Wound Pressure Injury Management. 2022 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

38.      Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177. doi:10.1016/j.jaad.2020.03.036

39.      Mawhirt SL, Frankel D, Diaz AM. Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers. Curr Allergy Asthma Rep. 2020;20(12):75. doi:10.1007/s11882-020-00974-w

40.      Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246-7. doi:10.1111/JDV.16471

41.      Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. doi:10.1016/j.trsl.2020.04.007

42.      Torrelo A, Andina D, Santonja C, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, et al. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol. 2020;37(3):442-6.

43.      Magro C, Nuovo G, Mulvey JJ, Laurence J, Harp J, Crowson AN. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clin Dermatol. 2021;39(6):934-65.

44.      Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol. 2020;34:e539-41.

45.      Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol. 2022;44(3):375-90.

 


 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.